menu
    • menu

    Company profile for Krystal Biotech

    NEW Drugs in Dev: 9
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Krystal Biotech, Inc. is a clinical-stage gene therapy company using its proprietary Skin TARgeted Delivery (STAR-D) platform to develop effective and innovative treatments for skin diseases. While we are initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications, we are expanding the use of our pioneering STAR-D technology to target and treat other skin conditio...
    Krystal Biotech, Inc. is a clinical-stage gene therapy company using its proprietary Skin TARgeted Delivery (STAR-D) platform to develop effective and innovative treatments for skin diseases. While we are initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications, we are expanding the use of our pioneering STAR-D technology to target and treat other skin conditions as well. Our goal is to make a meaningful difference in the lives of underserved patient populations suffering from debilitating skin diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Krystal BiotechUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2100 Wharton St. #701 Pittsburgh, PA 15203
    Telephone
    Telephone
    412-586-5830
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.krystalbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/krystal-biotech-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/KrystalBiotech

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Krystal Bio Reveals 2025 Q4 & Full-Year Financials
    Krystal Bio Reveals 2025 Q4 & Full-Year Financials

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239069/0/en/Krystal-Biotech-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-and-Operating-Results.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Krystal Biotech to Report Q4, FY 2025 Results Feb. 17, 2026
    Krystal Biotech to Report Q4, FY 2025 Results Feb. 17, 2026

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235224/0/en/Krystal-Biotech-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-17-2026.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Krystal Bio Receives FDA RMAT Designation For KB707 In Advanced
    Krystal Bio Receives FDA RMAT Designation For KB707 In Advanced

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234467/0/en/Krystal-Biotech-Announces-RMAT-Designation-Granted-by-FDA-to-KB707-for-the-Treatment-of-Advanced-or-Metastatic-Non-Small-Cell-Lung-Cancer.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Krystal Biotech Updates at 44th J.P. Morgan Healthcare Conference
    Krystal Biotech Updates at 44th J.P. Morgan Healthcare Conference

    11 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/11/3216487/0/en/Krystal-Biotech-Provides-Business-Update-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    11 Jan 2026
    Share Share
    Krystal Biotech Confirms CFTR Delivery in CF Patients
    Krystal Biotech Confirms CFTR Delivery in CF Patients

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215774/0/en/Krystal-Biotech-Announces-Positive-Interim-Clinical-Update-from-KB407-Phase-1-CORAL-1-Study-with-Confirmation-of-Wild-Type-CFTR-Delivery-to-the-Lungs-of-Patients-with-Cystic-Fibros.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Krystal Bio To Report Phase 1 KB407 Update In Cystic Fibrosis
    Krystal Bio To Report Phase 1 KB407 Update In Cystic Fibrosis

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214904/0/en/Krystal-Biotech-to-Announce-Interim-Clinical-Update-from-Highest-Dose-Cohort-of-Phase-1-CORAL-1-Study-Evaluating-KB407-in-Patients-with-Cystic-Fibrosis.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search